BioOrbit称在太空大规模制备蛋白晶体
2026-07-10 11:12:14
据彭博社报道，BioOrbit联合创始人兼CEO Katie King表示，公司在国际空间站执行创纪录任务，在微重力环境下实现蛋白晶体最大规模生产，产量较以往提高1至2个数量级。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
地缘政治 | 伊朗外交部：谴责巴基斯坦恐袭Next article：
Talus完成首期Talus/acc加速计划
